Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation-Reference-Cited by-同舟云学术

Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation

Published:2022-10-18 Issue:35 Volume:9 Page:2204335
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Yu Meihua¹,Yang Wei²,Yue Wenwen³,Chen Yu¹^ORCID

Affiliation:

1. Materdicine Lab School of Life Sciences Shanghai University Shanghai 200444 P. R. China

2. Department of Urology Xinhua Hospital School of Medicine Shanghai Jiaotong University 1665 Kongjiang Road Shanghai 200092 P. R. China

3. Shanghai Engineering Research Center of Ultrasound Diagnosis and Treatment Department of Medical Ultrasound Shanghai Tenth People's Hospital Ultrasound Research and Education Institute Tongji University Cancer Center Tongji University School of Medicine Shanghai 200072 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202204335

Reference199 articles.

1. Drug entrapment in liposomes

2. Clinical Translation of Nanomedicine

3. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

4. Enhancing cancer immunotherapy with nanomedicine

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy;International Immunopharmacology;2024-12

2. Tumor cell loaded thermosensitive hydrogel for photodynamic therapy associated tumor antigens release;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-11

3. T cell exhaustion in human cancers;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. Inosine pranobex-derived coordination complexes for self-adjuvant, self-carrier, and self-assembled vaccines in cancer immunotherapy;Applied Materials Today;2024-08

5. Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy;Acta Pharmacologica Sinica;2024-07-31